CL2011000786A1 - Suspension de nanocapsulas polimericas que comprende nanocapsulas con tamaño de particula entre 230-244 nm que incluye aceite de buriti, avobenzona, octocrileno y monoestearato de sorbitan en el nucleo el cual es encapsulado por el polimero poli (e-caprolactona) y polisorbato 80 y agua; composicion fotoprotectora y uso. - Google Patents

Suspension de nanocapsulas polimericas que comprende nanocapsulas con tamaño de particula entre 230-244 nm que incluye aceite de buriti, avobenzona, octocrileno y monoestearato de sorbitan en el nucleo el cual es encapsulado por el polimero poli (e-caprolactona) y polisorbato 80 y agua; composicion fotoprotectora y uso.

Info

Publication number
CL2011000786A1
CL2011000786A1 CL2011000786A CL2011000786A CL2011000786A1 CL 2011000786 A1 CL2011000786 A1 CL 2011000786A1 CL 2011000786 A CL2011000786 A CL 2011000786A CL 2011000786 A CL2011000786 A CL 2011000786A CL 2011000786 A1 CL2011000786 A1 CL 2011000786A1
Authority
CL
Chile
Prior art keywords
nanocapsules
avobenzone
octocrylene
caprolactone
polysorbate
Prior art date
Application number
CL2011000786A
Other languages
English (en)
Inventor
Adriana Raffin Pohlmann
Silvia Stanisçuaski Guterres
Alessandro Jäger
Original Assignee
Univ Federal Do Rio Grande Do Sul Ufrgs
Biolab Sanus Famaceutica Ltda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Federal Do Rio Grande Do Sul Ufrgs, Biolab Sanus Famaceutica Ltda filed Critical Univ Federal Do Rio Grande Do Sul Ufrgs
Publication of CL2011000786A1 publication Critical patent/CL2011000786A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11—Encapsulated compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/85—Polyesters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/413—Nanosized, i.e. having sizes below 100 nm

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Nanopartícula que comprende aceite y filtro UV; proceso para la preparación de dicha nanopartícula; uso de la nanopartícula; composición fotoprotectora; proceso para la preparación de dicha composición; y método de prevención de enfermedad de la piel.
CL2011000786A 2008-10-10 2011-04-08 Suspension de nanocapsulas polimericas que comprende nanocapsulas con tamaño de particula entre 230-244 nm que incluye aceite de buriti, avobenzona, octocrileno y monoestearato de sorbitan en el nucleo el cual es encapsulado por el polimero poli (e-caprolactona) y polisorbato 80 y agua; composicion fotoprotectora y uso. CL2011000786A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI0805854-7A BRPI0805854A2 (pt) 2008-10-10 2008-10-10 sistema nanoparticulado, processo de preparaÇço do mesmo, uso do mesmo, composiÇço fotoproterora, processo de preparaÇço da mesma, mÉtodo de prevenÇço de doenÇas e distérbios da pele

Publications (1)

Publication Number Publication Date
CL2011000786A1 true CL2011000786A1 (es) 2012-01-20

Family

ID=42101007

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2011000786A CL2011000786A1 (es) 2008-10-10 2011-04-08 Suspension de nanocapsulas polimericas que comprende nanocapsulas con tamaño de particula entre 230-244 nm que incluye aceite de buriti, avobenzona, octocrileno y monoestearato de sorbitan en el nucleo el cual es encapsulado por el polimero poli (e-caprolactona) y polisorbato 80 y agua; composicion fotoprotectora y uso.

Country Status (13)

Country Link
US (2) US9968533B2 (es)
EP (1) EP2344119B1 (es)
AR (1) AR073816A1 (es)
AU (1) AU2009301652B2 (es)
BR (1) BRPI0805854A2 (es)
CA (1) CA2740080C (es)
CL (1) CL2011000786A1 (es)
CO (1) CO6382104A2 (es)
ES (1) ES2757776T3 (es)
MX (1) MX341329B (es)
PL (1) PL2344119T3 (es)
WO (1) WO2010040194A2 (es)
ZA (1) ZA201103285B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9161983B2 (en) * 2012-06-15 2015-10-20 Vanderbilt University Linear polyester and semi-linear glycidol polymer systems: formulation and synthesis of novel monomers and macromolecular structures
US20140371179A1 (en) * 2013-06-13 2014-12-18 Professional Compounding Centers Of America Methods and Compositions for Treating Esophageal Diseases
FR3009682B1 (fr) 2013-08-13 2016-11-11 Polaar Suspension aqueuse de nanocapsules encapsulant des filtres solaires
CN103693674B (zh) * 2013-11-27 2015-11-18 上海纳米技术及应用国家工程研究中心有限公司 一种纳米氧化锌复合分散液的制备方法
US9745419B2 (en) 2014-01-24 2017-08-29 Vanderbilt University Aqueous polyglycidol synthesis with ultra-low branching
BR102014028002B1 (pt) * 2014-10-31 2019-10-22 Univ Estadual Campinas Unicamp processo de obtenção de carreadores lipídicos nanoestruturados em copolímero tribloco, carreadores lipídicos nanoestruturados assim obtidos, e seus usos
JP2019513359A (ja) * 2016-03-25 2019-05-30 アディッソ・フランス・エス．エー．エス．Ａｄｉｓｓｅｏ Ｆｒａｎｃｅ Ｓ．Ａ．Ｓ． 脂溶性の有効成分のナノカプセル並びにその製造方法及び使用方法
CN107519149A (zh) * 2017-08-30 2017-12-29 东华大学 一种负载三氯生的二氧化硅/cs/paa核壳复合纳米抗菌粒子的制备方法
CN110591314A (zh) * 2019-09-23 2019-12-20 昆明理工大学 一种控释型抗菌活性聚乳酸包装膜的制备方法
FR3104951B1 (fr) * 2019-12-23 2023-06-30 Oreal Compositions photoprotectrices des matières kératiniques
CN117503658A (zh) * 2023-12-05 2024-02-06 广东丸美生物技术股份有限公司 一种含有重组胶原蛋白的多效组合物及其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2659554B1 (fr) * 1990-03-16 1994-09-30 Oreal Composition pour le traitement cosmetique et/ou pharmaceutique des couches superieures de l'epiderme par application topique sur la peau et procede de preparation correspondant.
FR2681248B1 (fr) * 1991-09-13 1995-04-28 Oreal Composition pour un traitement cosmetique et/ou pharmaceutique de longue duree des couches superieures de l'epiderme par une application topique sur la peau.
JP4176912B2 (ja) 1999-05-10 2008-11-05 一丸ファルコス株式会社 保湿性植物抽出物を含有する化粧料組成物
EP1181000B1 (en) * 1999-05-25 2007-02-07 Sol-Gel Technologies Ltd. A method for obtaining photostable sunscreen compositions
BR0303404A (pt) 2003-05-13 2005-08-23 Chemyunion Quimica Ltda Uso do óleo da polpa dos frutos de palmeiras do gênero mauritia, como potencializador da protecção solar e como fonte de carotenoides (pró-vitamina a) e vitamina e (tocoferois) antioxidantes naturais em produtos cosméticos, capilares e farmacêuticos
US20050175651A1 (en) * 2004-01-09 2005-08-11 L'oreal Aqueous dispersion of nanocapsules with an oily core
US7001592B1 (en) 2005-01-31 2006-02-21 Aquea Scientific Corporation Sunscreen compositions and methods of use
DK1834635T3 (da) * 2006-03-13 2011-10-24 Advancell Advanced In Vitro Cell Technologies S A Stabile nanokapselsystemer til administrtion af aktive molekyler
JP2010512244A (ja) * 2006-12-12 2010-04-22 ソル − ゲル テクノロジーズ リミテッド 金属酸化物シェルを有するナノメートルコアシェル粒子の形成
KR20100039395A (ko) * 2007-07-09 2010-04-15 바스프 에스이 지용성 유기 ｕｖ 흡수제의 수계 농축 생성물 형태

Also Published As

Publication number Publication date
CA2740080A1 (en) 2010-04-15
WO2010040194A3 (en) 2010-06-03
AU2009301652A1 (en) 2010-04-15
ES2757776T3 (es) 2020-04-30
AR073816A1 (es) 2010-12-01
US10016350B2 (en) 2018-07-10
CO6382104A2 (es) 2012-02-15
CA2740080C (en) 2018-03-20
WO2010040194A2 (en) 2010-04-15
PL2344119T3 (pl) 2020-06-01
US20110262531A1 (en) 2011-10-27
EP2344119B1 (en) 2019-09-11
US20160256372A1 (en) 2016-09-08
ZA201103285B (en) 2012-05-30
MX341329B (es) 2016-08-15
BRPI0805854A2 (pt) 2010-08-24
EP2344119A2 (en) 2011-07-20
EP2344119A4 (en) 2014-07-09
US9968533B2 (en) 2018-05-15
AU2009301652B2 (en) 2016-01-21
MX2011003810A (es) 2011-09-01

Similar Documents

Publication Publication Date Title
CL2011000786A1 (es) Suspension de nanocapsulas polimericas que comprende nanocapsulas con tamaño de particula entre 230-244 nm que incluye aceite de buriti, avobenzona, octocrileno y monoestearato de sorbitan en el nucleo el cual es encapsulado por el polimero poli (e-caprolactona) y polisorbato 80 y agua; composicion fotoprotectora y uso.
LTC2444424I2 (lt) Pagerintos TM nanodalelės, skirtos agregacijos sąlygotų sutrikimų gydymui
BRPI0814957A2 (pt) Composto, pró-droga, agente farmacêutico, método para a profilaxia ou tratamento de uma doença, distúrbio ou condição, e, uso do composto.
DE602006015665D1 (de) Probiotische enterokokken für eine verbesserte immunität
CL2009000380A1 (es) Compuestos derivados de heterociclos, moduladores de beta-amiloide; proceso de preparacion; composicion farmaceutica; y uso en el tratamiento de la enfermedad de alzheimer, angioplastia cerebral amiloide, demencia multiinfarto, sindrome de down, entre otras.
CR10150A (es) Formulaciones de aceite
BRPI0822756A2 (pt) sistema de prótese de válvula cardíaca e processo para produzir prótese de válvula cardíaca.
MX2010007076A (es) Nanodispersion.
BRPI0911350A2 (pt) conjugado de polietileno glicol, método para tratar hemofilia b, e, método para reduzir o risco de doenças ou condições.
AR094422A1 (es) Concentración de suspensiones
BR0314530A (pt) Nanopartìculas magnéticas e método de fabricação
MX2010002926A (es) Moduladores de tieno y furo-pirimidina del receptor h4 de histamina.
WO2009098404A8 (fr) Procédé de préparation de nanoparticules à base de molécules ou macromolécules amphiphiles fonctionnelles et leur utilisation
FR2895412B1 (fr) Procede de preparation de nanoparticules en feuillets et nanoparticules obtenues.
AR075686A1 (es) Nanoparticulas de policosanol
WO2011119903A3 (en) Emulsions for microencapsulation comprising biodegradable surface-active block copolymers as stabilizers
UY31692A (es) Formulacion en suspension para adsorbentes de carbono
ITMN20050001A1 (it) Sistema di produzione di dischi per freni e relativo prodotto ottenuto
Patta THE EFFECTS OF ECONOMIC CONDITION IN JOHN STEINBECK'S THE GRAPES OF WRATH
FR2937249B1 (fr) Nouvelles utilisations pharmaceutiques de nanoparticules.
ES1058852Y (es) Sistema de preparacion integral del automovil.
ITMI20061302A1 (it) Metodo e composizione per la cura e-o manutenzione dei gruppi macinatori di macchine per caffe' superautomatiche,macinadosatori e macinacaffe'.
BRPI0812552A2 (pt) Processo para fabricação de partículas núcleo-casca de perfume, dispersão aquosa de partículas e uso da mesma
ITRA20040012U1 (it) Sistema di gonfiaggio particolarmente idoneo per le zattere di salvataggio.
ITPG20070070A1 (it) Trattamento idro-termico per la eco-scomposizione e compattazione di sostanze organiche in ambiente inerte.